Oncology Institute, Inc.·4

Mar 25, 9:33 AM ET

Chernett Jorey 4

Research Summary

AI-generated summary

Updated

Oncology Institute (TOI) 10% Owner Chernett Jorey Buys 125,000 Shares

What Happened
Chernett Jorey, listed as a 10% owner of Oncology Institute, Inc. (TOI), made an open-market purchase of 125,000 shares on 2026-03-24. The filing reports a weighted average purchase price of $3.11 per share, for a total reported outlay of $388,750. This was a purchase transaction (code P), which investors often view as a more bullish signal than a sale.

Key Details

  • Transaction date: 2026-03-24; Form 4 filed: 2026-03-25 (timely filing).
  • Reported price: weighted average $3.11 per share; total reported value $388,750.
  • Price range: purchases occurred at prices from $3.04 to $3.15 per share (rounded to the nearest cent) — see footnote F1. The weighted average is rounded to the nearest cent.
  • Shares acquired: 125,000.
  • Shares owned after transaction: not specified in the filing.
  • Insider status: 10% owner (not an executive-level label); transaction code P = Purchase.
  • Footnote F1: confirms the $3.11 figure is a weighted average across multiple trades and states Mr. Chernett will provide a breakdown of quantities at each price upon request to the issuer, SEC staff, or holders.

Context
As a 10% owner, Chernett Jorey is a significant holder rather than necessarily an operating executive; such purchases can reflect a major holder adding to a position but do not by themselves explain motivation. Because the filing shows multiple trades aggregated into a weighted average price, interested investors can request the per-trade detail referenced in F1 for more granularity.